Medical Device

TSO3 released their financial results for the second quarter of 2017.

TSO3 (TSX:TOS) released their financial results for the second quarter of 2017.
As quoted in the press release:

Management Commentary
“We are pleased with our continued operating performance in the second quarter of 2017 as we supported Getinge to market and sell our STERIZONE® VP4 Sterilizers in hospitals in North America and Europe,” stated R. M. (Ric) Rumble, TSO3‘s President and CEO.  “We made significant progress during the quarter toward our duodenoscope regulatory claim strategy, enhancing our products and improving our production and service methods.  We are looking forward to the months to come.”

Click here to read the full press release.

Source: www.newswire.ca

Featured

MARKETS

Markets
TSX20286.20+88.59
TSXV700.66-1.43
DOW31928.62+48.38
S&P 5003941.48-32.27
NASD11264.45-270.83
ASX7128.80-20.10

COMMODITIES

Commodities
Gold1856.29-11.01
Silver21.87-0.26
Copper4.25-0.05
Palladium1995.00-2.00
Platinum947.75-8.26
Oil110.85+1.08
Heating Oil3.71+0.06
Natural Gas8.82+0.03

DOWNLOAD FREE REPORTS

×